Showing results (221-230 of 301) with videos related to
Sort By:
Pageof 31
The Journal of Biological Chemistry|November 25, 1992
Interaction between the p21ras GTPase activating protein and the insulin receptorG J Pronk, R H Medema, B M Burgering, et al.Science (New York, N.Y.)|July 13, 1990
Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene productM Frech, J John, V Pizon, et al.Nature Medicine|June 1, 1997
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsC Heise, A Sampson-Johannes, A Williams, et al.Science (New York, N.Y.)|October 4, 1985
A model for the tertiary structure of p21, the product of the ras oncogeneF McCormick, B F Clark, T F la Cour, et al.Cell|November 16, 1990
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21G A Martin, D Viskochil, G Bollag, et al.Cureus|January 27, 2025
Knee Ligament Injuries in the National Football League: Impact of Field Surface Type During the 2020-2023 SeasonsWilliam F McCormick, Mitchell J Lomis, Christian B Cooper, et al.Cancer Research|December 1, 1986
Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12G Wong, N Arnheim, R Clark, et al.Science (New York, N.Y.)|January 10, 1992
GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currentsG A Martin, A Yatani, R Clark, et al.The New England Journal of Medicine|March 3, 1994
Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disordersK M Shannon, P O'Connell, G A Martin, et al.Oncogene|April 1, 1990
Retrospective analysis of ras gene activation in myeloid leukemic cellsM Lübbert, D Jonas, C W Miller, et al.Pageof 31